Australia Diabetes Market will reach US$ 5.96 Billion in 2028 and it will expand at a CAGR of 7.14% from 2022 to 2028, according to the publisher. In recent years, Australia diabetes has been on the rise. The diabetes burden in Australia shows no sign of slowing, and its health and economic impact continue to be felt by people with diabetes. Almost 1.9 million Australians have diabetes and it is the seventh most common cause of death by disease. Australia is home to an aging population and the Australian Government, like other governments worldwide, faces the challenge of dealing with the issue of rising healthcare costs. Obesity is an increasingly serious issue for Australia. The number of people with type 2 diabetes is growing, most likely the result of rising overweight and obesity rates, lifestyle and dietary changes, and an ageing population. Australia Diabetes Market was US$ 3.94 Billion in 2022.Australia Diabetes Market was US$ 3.94 Billion in 2022
Type 2 Diabetes is Increasing Year on Year
The number of people living with diabetes in Australia increased almost 2.8-fold between 2000 and 2020. Currently, 134 thousand Australians are living with type 1 diabetes. Type 1 diabetes is usually confirmed with an extra blood test to check autoantibodies. However, type 2 diabetes is increasing at the fastest rate in Australia. Type 2 diabetes is one of the significant consequences of the modern lifestyle. In addition, the number of people with silent, undiagnosed type 2 diabetes may be damaging their bodies. An estimated 2 million Australians are at high risk of developing type 2 diabetes and are already showing early signs of the condition.Growing Number of Diabetes cases in Australia will create demand for Insulin Pens
The Australian diabetes market is classified into Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring (CGM) Devices, Insulin pens, and Insulin Pumps. The growing adoption of insulin-delivery devices and the rising prevalence of diabetes are driving market growth. Therefore, leading Australian manufacturers are focusing on technological innovations and developing advanced products to gain a substantial market share. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure in Australia are indications of the increasing usage of diabetic care products.After Insulin Pens, CGMs accounted for the largest share of the Australian diabetes market. Increasing adoption of CGM systems, development of advanced CGM systems, favorable government policies, and promotion of the adoption of CGM devices are the key factors contributing to this segment capturing maximum share and highest growth.
Australian Government has developed a National Diabetes Strategy
The government plays a significant role in assuring that people with diabetes can access affordable, high-quality equipment and services to help in self-management and care. The National Diabetes Services Plan, the Prescription Benefits Scheme, the Insulin Pump Program, and Medicare are all initiatives the Australian government administers to assist people with diabetes.More than 3.1 million Australians will live with diabetes by 2050; around one in every 12 Australians, According to Diabetes Australia administers the National Diabetes Services Scheme (NDSS). Direct healthcare, hospital costs, and medicines have exploded in the past two decades, while hospitalizations have increased since 2004. The diabetes epidemic is one of the most significant health challenges Australia has ever faced, and it calls for unified and sustained action.
Key Players Analysis
The major players are B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Corporations, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care.In January 2021, the National Diabetes Services Scheme (NDSS) Australia approved using the Dexcom G6 CGM device through the NDSS Subsidy Initiative if diabetes patients use a Tandem t: slim X2 insulin pump and meet the NDSS criteria.
In Feb 2020, the Australian government initiated USD 300 Million CGM (Continuous Glucose Monitoring) (FreeStyleLibre flash glucose monitoring system) free access to eligible type-1 diabetes patients.
This report titled “AustraliaDiabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self-Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Insulin Pen Analysis - (User, Types - Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump Analysis- (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies) Companies (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Cororation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of Australia Insulin Delivery Devices Market.
Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)2. Self Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump
Australia Diabetes Sub-Segment Analysis
1. Continuous Glucose Monitoring (CGM)1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement
2. SMBG
1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
3. Insulin Pen Market
1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies
4. Insulin Pump Market
1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies
All the 13 Companies Studied in the Report have been Studied from 3 Points
- Company Overview
- Recent Developments
- Financial Insight
Company Analysis
1. B. Braun Melsungen AG2. Eli Lilly and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nardisk
6. Ypsomed AG
7. Medtronic
8. InsuletCororation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care
12. Roche Diagnostic
13. Tandem Diabetes Care
Table of Contents
1. Introduction2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Australia Diabetes Market
6. Australia Diabetes Population
6.1 Type 1 Diabetes
6.2 Type 2 Diabetes
7. Market Share - Australia Diabetes Analysis
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) - Market & Users
8.1 CGM Market by Components
8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market
8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in Australia
9. Blood Glucose Device (SMBG) - Australia Market & Users
9.1 Market
9.1.1 Type 1 Diabetes Market
9.1.2 Type 2 Diabetes Market
9.2 Test Strips Market
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.3 Lancet Market
9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes
9.4 Meter Market and Forecast
9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes
9.5 Blood Glucose (SMBG) Users
9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes
9.6 Reimbursement Policies of Blood Glucose Devices in Australia
10. Insulin Pen - Australia Market & User Analysis
10.1 Insulin Pen Market
10.1.1 Disposable Insulin Pen Market
10.1.2 Reusable Insulin Pen Market
10.1.3 Smart Insulin Pen Market
10.2 Insulin Pen User
10.2.1 Disposable Insulin Pen User
10.2.2 Reusable Insulin Pen User
10.2.3 Smart Insulin Pen User
10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies of Insulin Pen in Australia
11. Insulin Pump - Australia Market & Users
11.1 Insulin Pump Market
11.1.1 Type 1 Diabetes Market
11.1.2 Type 2 Diabetes Market
11.2 Insulin Pump User
11.2.1 Type 1 Insulin Pump User
11.2.2 Type 2 Insulin Pump User
11.3 Differentiation Points of Insulin Pump Products in Australia
11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 Insulet OmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo
11.4 Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
11.4.1 Medtronic
11.5 Insulet Corporation
11.5.1 Training Structure for New Patients - Insulet Corporation
11.6 Animas Corporation
11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)
11.7 Tandem Diabetes Care
11.8 Reimbursement Policies Insulin Pump
12. Insulin Pen - Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Recent Developments
12.2.3 Revenue
12.3 Terumo Corporation
12.3.1 Overview
12.3.2 Recent Developments
12.3.3 Revenue
12.4 BD
12.4.1 Overview
12.4.2 Recent Developments
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Recent Developments
12.5.3 Revenue
12.6 Ypsomed AG
12.6.1 Overview
12.6.2 Recent Developments
12.6.3 Revenue
13. Insulin Pump - Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue
13.2 Insulet Corporation
13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue
14. SMBG - Company Analysis
14.1 LifeScan Inc.
14.1.1 Overview
14.1.2 Recent Developments
14.1.3 Revenue
14.2 Abbott Laboratories
14.2.1 Overview
14.2.2 Recent Developments
14.2.3 Revenue
15. CGM - Company Analysis
15.1 Dexcom Inc
15.1.1 Overview
15.1.2 Recent Developments
15.1.3 Revenue
15.2 Roche
15.2.1 Overview
15.2.2 Recent Developments
15.2.3 Revenue
15.3 Tandem Diabetes Care
15.3.1 Overview
15.3.2 Recent Developments
15.3.3 Revenue
List of Figures:
Figure 01: Australia - Diabetes Market (Billion US$), 2017 - 2022
Figure 02: Australia - Forecast for Diabetes Market (Billion US$), 2023 - 2028
Figure 03: Australia - Type 1 Diabetes Population (Thousand), 2017 - 2022
Figure 04: Australia - Forecast for Type 1 Diabetes Population (Thousand), 2023 - 2028
Figure 05: Australia - Type 2 Diabetes Population (Thousand), 2017 - 2022
Figure 06: Australia - Forecast for Type 2 Diabetes Population (Thousand), 2023 - 2028
Figure 07: Australia - Glucose Sensor Market (Million US$), 2017 - 2023
Figure 08: Australia - Forecast for Glucose Sensor Market (Million US$), 2023 - 2028
Figure 09: Australia - CGM Transmitter Market (Million US$), 2017 - 2023
Figure 10: Australia - Forecast for CGM Transmitter Market (Million US$), 2023 - 2028
Figure 11: Australia - CGM User (Thousand), 2017 - 2023
Figure 12: Australia - Forecast for CGM User (Thousand), 2023 - 2028
Figure 13: Australia - Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 14: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 15: Australia - Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 16: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 17: Australia - Test Strips Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 18: Australia - Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 19: Australia - Test Strips Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 20: Australia - Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 21: Australia - Lancet Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 22: Australia - Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 23: Australia - Lancet Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 24: Australia - Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 25: Australia - Meter Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 26: Australia - Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 27: Australia - Meter Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 28: Australia - Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 29: Australia - Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 - 2022
Figure 30: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 - 2028
Figure 31: Australia - Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 - 2022
Figure 32: Australia - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 - 2028
Figure 33: Australia - Disposable Insulin Pen Market (Million US$), 2017 - 2023
Figure 34: Australia - Forecast for Disposable Insulin Pen Market (Million US$), 2023 - 2028
Figure 35: Australia - Reusable Insulin Pen Market (Million US$), 2017 - 2023
Figure 36: Australia - Forecast for Reusable Insulin Pen Market (Million US$), 2023 - 2028
Figure 37: Australia - Smart Insulin Pen Market (Million US$), 2017 - 2023
Figure 38: Australia - Forecast for Smart Insulin Pen Market (Million US$), 2023 - 2028
Figure 39: Australia - Disposable Insulin Pen User (Thousand), 2017 - 2022
Figure 40: Australia - Forecast for Disposable Insulin Pen User (Thousand), 2023 - 2028
Figure 41: Australia - Reusable Insulin Pen User (Thousand), 2017 - 2022
Figure 42: Australia - Forecast for Reusable Insulin Pen User (Thousand), 2023 - 2028
Figure 43: Australia - Smart Insulin Pen User (Thousand), 2017 - 2022
Figure 44: Australia - Forecast for Smart Insulin Pen User (Thousand), 2023 - 2028
Figure 45: Australia - Insulin Pen Needle Market (Million US$), 2017 - 2023
Figure 46: Australia - Forecast for Pen Needle Market (Million US$), 2023 - 2028
Figure 47: Australia - Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 48: Australia - Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 49: Australia - Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 50: Australia - Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 51: Australia - Insulin Pump Type 1 Users (Thousand), 2017 - 2022
Figure 52: Australia - Forecast for Insulin Pump Type 1 Users (Thousand), 2023 - 2028
Figure 53: Australia - Insulin Pump Type 2 Users (Thousand), 2017 - 2022
Figure 54: Australia - Forecast for Insulin Pump Type 2 Users (Thousand), 2023 - 2028
Figure 55: B. Braun Melsungen AG - Global Revenue (Billion US$), 2017 - 2022
Figure 56: B. Braun Melsungen AG - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 57: Eli Lilly - Global Revenue (Million US$), 2017 - 2022
Figure 58: Eli Lilly - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 59: Terumo Corporation - Global Revenue (Billion US$), 2017 - 2022
Figure 60: Terumo Corporation - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 61: BD - Global Revenue (Billion US$), 2017 - 2022
Figure 62: BD - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 63: Novo Nordisk A/S - Global Revenue (Million US$), 2017 - 2022
Figure 64: Novo Nordisk A/S - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 65: Ypsomed AG - Global Revenue (Million US$), 2017 - 2022
Figure 66: Ypsomed AG - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 67: Medtronic - Global Revenue (Billion US$), 2017 - 2022
Figure 68: Medtronic - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 69: Insulet Corporation - Global Revenue (Million US$), 2017 - 2022
Figure 70: Insulet Corporation - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 71: DarioHealth Corp - Global Revenue (Million US$), 2017 - 2022
Figure 72: DarioHealth Corp - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 73: Abbott Laboratories - Global Revenue (Billion US$), 2017 - 2022
Figure 74: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 75: Dexcom Inc - Global Revenue (Billion US$), 2017 - 2022
Figure 76: Dexcom Inc - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 77: Roche - Global Revenue (Billion US$), 2017 - 2022
Figure 78: Roche - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 79: Tandem Diabetes Care - Global Revenue (Million US$), 2017 - 2022
Figure 80: Tandem Diabetes Care - Forecast for Global Revenue (Million US$), 2023 - 2028
List of Tables:
Table 01: Australia - Diabetes Market Share by Type (Percent), 2017 - 2022
Table 02: Australia - Forecast for Diabetes Market Share by Type (Percent), 2023 - 2028
Companies Mentioned
- B. Braun Melsungen AG
- Eli Lilly and Company
- Terumo Corporation
- Becton, Dickinson (BD)
- Novo Nardisk
- Ypsomed AG
- Medtronic
- InsuletCororation
- Abbott Laboratories
- DarioHealth Crop
- Dexcom, Inc
- Roche Diagnostic
- Tandem Diabetes Care
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 190 |
| Published | March 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 3.94 Billion |
| Forecasted Market Value ( USD | $ 5.96 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Australia |
| No. of Companies Mentioned | 13 |
